Childhood asthma – how to recognize and treat? Review article
Article Sidebar
Main Article Content
Abstract
Asthma in children up to 5 years of age is a disease that is diagnosed on the basis of the clinical symptoms of bronchial obstruction, such as: wheezing, cough and shortness of breath of variable intensity and duration, clinically proven reversibility of obstruction and clinical improvement after chronic use of inhaled glucocorticosteroids and lack of grounds for suspecting causes of obstruction other than asthma. Treatment of childhood asthma is a graded therapy with a range of intensity to control the course of the disease and the main form of treatment is inhalation therapy. During the COVID-19 pandemic, it is necessary to continue treatment in accordance with the previously adopted principles, including the use of inhaled glucocorticosteroids.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright: © Medical Education sp. z o.o. This is an Open Access article distributed under the terms of the Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). License (https://creativecommons.org/licenses/by-nc/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Address reprint requests to: Medical Education, Marcin Kuźma (marcin.kuzma@mededu.pl)
References
2. Bręborowicz A, Lis G, Niżankowska-Mogilnicka E et al. Rozpoznawanie i leczenie astmy u dzieci. Medycyna Praktyczna Pediatria. 2020; 4(130): 49-74.
3. Doniec Z, Mastalerz-Migas A, Bręborowicz A et al. Recommendations for management of preschool asthma for General Practitioners – COMPAS GP. Fam Med Prim Care Rev. 2016; 18(2): 181-92.
4. Doniec Z, Woźniak M, Woźniak K et al. Astma wczesnodziecięca – praktyczne problemy kliniczne. Alergoprofil. 2017; 13(2): 49-54.
5. Ducharme FM, Dell SD, Radhakrishnan D et al. Diagnosis and management of asthma in preschoolers: A Canadian Thoracic Society and Canadian Paediatric Society position paper. Can Respir J. 2015; 22(3): 135-43.
6. Jaworska J, Komorowska-Piotrowska A, Pomiećko A et al. Consensus on the Application of Lung Ultrasound in Pneumonia and Bronchiolitis in Children. Diagnostics. 2020; 10(11): 935. http://doi.org/10.3390/diagnostics10110935.
7. Rozporządzenie Ministra Zdrowia z 5 marca 2021 r. zmieniające rozporządzenie w sprawie standardu organizacyjnego teleporady w ramach podstawowej opieki zdrowotnej (Dz.U. 2021 poz. 427).
8. de Benedictis FM, Attanasi M. Asthma in childhood. Europ Respir Rev. 2016; 25: 41-7. http://doi.org/10.1183/16000617.0082-2015.
9. Profesjonalny oczyszczacz powietrza Fellowes AeraMax Pro AM3. (access: 23.03.2021).
10. Inteligentne inhalatory do zdalnej terapii astmy. (access: 22.03.2021).
11. Aerogen: Pioneering aerosol drug delivery. Clinical White Paper (access: 22.03.2021).
12. Boechat JE, Wandalsen GF, Kuschnir FC et al. COVID-19 and Pediatric Asthma: Clinical and Management Challenges. Int J Environ Res Public Health. 2021; 18(3): 1093. http://doi.org//10.3390/ijerph18031093.
13. Kowalski ML, Bartuzi Z, Bręborowicz A et al. Stanowisko grupy ekspertów Polskiego Towarzystwa Alergologicznego w sprawie postępowania u chorych na astmę i choroby alergiczne w okresie pandemii SARS-CoV-2. Alergologia Polska – Polish Journal of Allergology. 2020; 7(2): 1-7.
14. Emeryk A, Pirożyński M, Mazurek H et al. Stanowisko polskich ekspertów dotyczące nebulizacji w okresie pandemii COVID-19. Terapia. 2020; 4(387): 12-16.